Recommendation Paper on Advancing the Use of Decentralised Elements in Clinical Trials.
The expansion of the use of decentralised elements in clinical trials in the European Union is driven by the opportunities they offer, including their potential to enhance trial access and improve research outcomes. Despite these potential benefits, several regulatory, operational, and technological...
| Publicado en: | Therapeutic Innovation & Regulatory Science Vol. 59; no. 6; pp. 1211 - 1219 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | practice guidelines tables/charts Journal Article |
| Publicado: |
Springer Nature
Nov2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |